Effect of 4-methoxymethylpyridoxine on gangliosides, cholesterol and fatty acids in mouse brain.
D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects*; D002554:Cerebrosides / Q000302:isolation & purification; D002784:Cholesterol / Q000032:analysis*; D002849:Chromatography, Gas; D004987:Ethers / Q000494:pharmacology; D005227:Fatty Acids / Q000032:analysis*; D005260:Female; D005732:Gangliosides / Q000032:analysis*; D008297:Male; D051379:Mice; D009438:Neuraminic Acids / Q000032:analysis; D011736:Pyridoxine / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000031:analogs & derivatives; D013107:Sphingolipids / Q000032:analysis; D013431:Sulfates / Q000032:analysis; D026681:Vitamin B 6 Deficiency / Q000378:metabolism
D002554:Cerebrosides; D004987:Ethers; D005227:Fatty Acids; D005732:Gangliosides; D009438:Neuraminic Acids; D013107:Sphingolipids; D013431:Sulfates; C001737:4-methoxymethylpyridoxine; D002784:Cholesterol; D011736:Pyridoxine